World Bulletin/News Desk
The World Health Organization has endorsed using HIV medicines among people who do not have the infection but are at high risk of getting it, and suggested that poor and wealthy countries alike set up pilot projects to better understand the benefits.
The United Nations agency made its suggestion on Friday, four days after U.S. regulators approved use of Gilead Sciences Inc's Truvada for people who are not infected but may engage in sexual activity with HIV-positive partners. The concept is known as pre-exposure prophylaxis (PrEP).
Truvada, which combines the anti-HIV drugs tenofovir and emtricitabine in one pill, is widely used to treat people already infected with the virus that causes AIDS. The medicine, which costs almost $14,000 a year in the United States, is the first treatment also approved for prevention.
"WHO is encouraging countries wishing to introduce PrEP to first establish small projects to help public health workers to better understand and realize its potential benefits," the agency said in a statement. It said appropriate HIV medicines should be given to those at high risk of infection.
"These could include men or transgender women who have sex with men," the group said.
WHO spokeswoman Sarah Russell said the agency could not recommend specific drugs for prevention, but she said, "It needs to be a drug like Truvada that has been developed for prevention purposes."
Russell said WHO expects Gilead to make Truvada available at a deeply discounted price in some poor countries.
"We believe Gilead will bring the price down to about $100 per year per person" in those countries, she said in an interview.
Gilead officials could not immediately be reached for comment.
WHO noted that an international study called Partners PrEP has shown that HIV medicines are highly effective at preventing the illness in men and women whose partners are infected.
That study, conducted in Kenya and Uganda and funded by the Bill & Melinda Gates Foundation, involved taking a daily tablet containing tenofovir or tenofovir in combination with emtricitabine.
The U.N. agency said it would evaluate the outcomes of the small projects, along with evolving scientific evidence, before issuing its own detailed guidelines next year on the use of HIV treatments for prevention.
WHO said it was important that people taking HIV drugs for prevention are HIV-negative because otherwise drug resistant forms of HIV could evolve. The agency said they should also continue using condoms and faithfully take their medicines on a daily basis.
Indian government issues guidelines to deal with Zika virus
Number just 1 million shy of those who would have been without coverage under previous Republican draft
The human genome has some 25,000 genes composed of more than three billion pairing of building-block molecules.
On a pro-forma 2016 basis, the merged group would have combined sales of approximately $13.2 billion (11.8 billion euros) and underlying or operating profit of $2.3 billion.
The seed vault that protects the worlds' seed crops, also protects European and South American varieties of aubergine, lettuce, barley and potatoes.
Early polls indicated broad support for the plan, but the most recent survey, published on May 10, showed the "yes" side slipping to 56 percent -- a drop of five points from late March.
Authorities declare quarantine against movement of chicken and ducks
Cholera cases in country could reach 300,000 within six months, WHO Yemen representative says
In recent years rangers have tried to clean up Khao Sam Roi Yot national park and this year were rewarded with a sea of pink flowers.
Over 17,200 suspected cases of cholera were reported in Yemen
Cholera has hit 13 of 18 Somalia’s provinces, in biggest outbreak in the country in 5 years, according to WHO
The fate of the superhighway remains on hold pending the final decision of the Abuja authorities, expected in the coming weeks.
The new policy would also help guarantee the labor and human rights of the six million small farmers and 30 million workers who harvest rubber in countries such as Indonesia, Thailand and Brazil.
Turkey makes strides in developing its medical tourism sector by implementing policies that facilitate foreign visitors
A prolonged drought descended on the region last year, shriveling two rivers that feed into Lake Atescatempa, and with it the flow of tourists to the area and the livelihood of residents.
The WHO says that pre-term birth complications in Indonesia are the leading cause of death among children under five.